Search

The article reports that a study funded by the U.S. National Institutes of Health found that administering AIDS drugs to HIV patients rendered them significantly less infectious. Myron Cohen of the Institute for Global Health and Infectious Diseases at the University of North Carolina led the study, which involved 1,763 couples, one each of which had HIV.

The article reports that clinical research shows women are able to significantly reduce their chances of becoming infected by the HIV virus by applying a gel containing the antiretroviral drug tenofovir both before and after sexual intercourse. Conducted by the AIDS Programme of Research in South Africa, the study holds promise for fighting AIDS in that nation and elsewhere in Africa.

The article reports that scientists at the Vaccine Research Center of the U.S. National Institute of Allergy and Infectious Diseases have discovered antibodies capable of neutralizing up to 90 percent of known strains of the HIV virus. The antibodies were discovered in the cells of a 60-year old gay man. Gary Nabel, one of the researchers, states that developing a vaccine which would allow other persons to develop the antibodies is a long-term project.

The article reports on the result of a research conducted at the Ragon Institute, a joint project of Massachusetts General Hospital, the Massachusetts Institute of Technology (MIT) and Harvard University, which investigated the possibility that some HIV sectors or group pf amino acids can be targeted for AIDS vaccines or drugs.

The article reports on the discovery by the National Institute of Allergy and Infectious Diseases suggesting that the virus which causes AIDS does not infect the human body easily and HIV's difficulties can be used to determine potential prevention and treatment methods.

Reports the Clinton Foundation, created by former United States President Bill Clinton, plans to announce deals with several of the world's leading medical companies to cut prices of two HIV diagnostic tests in developing nations. Comments from Jim Kim, adviser to the Director General of the World Health Organization, regarding the importance of diagnostic pricing; Concern among activists related to the test's ease of use in impoverished countries; Discussion of diagnostic pricing; View of doctors regarding the benefits of the tests on the drug treatment regimen given to patients; What the companies are including along with the test kits, including training and the machines necessary to run the tests; Companies that have signed the deal with the Clinton Foundation; Cost to the countries for the CD4 tests.

Profiles Richard Holbrooke, a former United States ambassador to the United Nations who is working to encourage multinational companies that do business in areas with high incidence of AIDS and HIV to deal with diseased employees. His leadership of the Global Business Council on HIV/AIDS; Methods by which he hopes to improve conditions for workers with HIV or AIDS.

Reports that more drug-resistant strains of HIV, the AIDS disease virus, are being spread from person to person, according to researchers at a major AIDS conference in Chicago, Illinois in January 2001.